Over the past decade, rapid progress had been made in elucidating the cellular and molecular mechanisms of new blood vessel formation in both health and disease. Lack of sufficient angiogenesis (new capillary development) and collateral formation (remodeling of existing blood vessels) in adult tissues (e. g., heart, brain, skeletal muscle) during criti- cal ischemia has prompted novel therapeutic strategies to stimulate/fa- cilitate angiogenesis and collateral formation in ischemic conditions ("therapeutic angiogenesis"). ...
Read More
Over the past decade, rapid progress had been made in elucidating the cellular and molecular mechanisms of new blood vessel formation in both health and disease. Lack of sufficient angiogenesis (new capillary development) and collateral formation (remodeling of existing blood vessels) in adult tissues (e. g., heart, brain, skeletal muscle) during criti- cal ischemia has prompted novel therapeutic strategies to stimulate/fa- cilitate angiogenesis and collateral formation in ischemic conditions ("therapeutic angiogenesis"). Therapeutic angiogenesis describes a strategy of inducing new col- lateral vessels that can bypass vascular obstructions caused by atherosclerotic disease and stimulating new capillaries that can en- hance tissue oxygen exchange. Naturally occurring growth factors (e. g., FGFs, VEGFs) have been identified and demonstrated to induce new blood vessel formation in the adult organism. The therapeutic ap- plication of these growth factors has been demonstrated to enhance these natural processes and have been shown in a number of animal models to increase blood flow and oxygen exchange to ischemic tis- sues. Therapeutic angiogenesis therefore represents a new medical principle that is anticipated to be used as an adjunct or alternative to angioplasty and/or bypass surgery. A number of strategies have been proposed and tested to deliver growth factors. One strategy is the direct administration of the growth factor protein by intramuscular, intraarte- rial or intravenous delivery.
Read Less
Add this copy of Therapeutic Angiogenesis (Ernst Schering Foundation to cart. $14.04, Sold by Zubal Books rated 5.0 out of 5 stars, ships from Cleveland, OH, UNITED STATES, published 1999 by Springer.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
*Price has been reduced by 10% until Monday, Feb. 24 (Weekend sale item)* 181 pp., hardcover, ex library, else text and binding clean and tight. -If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Add this copy of Therapeutic Angiogenesis (Ernst Schering Foundation to cart. $14.52, good condition, Sold by Project HOME rated 4.0 out of 5 stars, ships from Philadelphia, PA, UNITED STATES, published 1999 by Springer.
Add this copy of Therapeutic Angiogenesis [Ernst Schering Research to cart. $19.00, very good condition, Sold by Tiber Books rated 4.0 out of 5 stars, ships from Cockeysville, MD, UNITED STATES, published 1999 by Springer, Berlin / New York.
Add this copy of Therapeutic Angiogenesis (Ernst Schering Foundation to cart. $47.73, very good condition, Sold by Dotcom liquidators / dc1 rated 4.0 out of 5 stars, ships from Fort Worth, TX, UNITED STATES, published 1999 by Springer.
